In last trading session, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) saw 1,217,887 shares changing hands with its beta currently measuring 2.09. Company’s recent per share price level of $3.16 trading at $0 or 2.6% at ring of the bell on the day assigns it a market valuation of $368.04 Million. That closing price of SPPI’s stock is at a discount of -234.49% from its 52-week high price of $10.57 and is indicating a premium of 44.94% from its 52-week low price of $1.74. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.53 Million shares which gives us an average trading volume of 1.23 Million if we extend that period to 3-months.

For Spectrum Pharmaceuticals, Inc. (SPPI), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2.2. Splitting up the data highlights that, out of 5 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 3 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.32 in the current quarter.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) trade information

Upright in the green today for gaining 2.6%, in the last five days SPPI remained trading in the green while hitting it’s week-highest on Tuesday, Jun 23 when the stock touched $3.41-7 price level, adding 7.47% to its value on the day. Spectrum Pharmaceuticals, Inc.’s shares saw a change of -13.19% in year-to-date performance and have moved 1.77% in past 5-day. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) showed a performance of 2.27% in past 30-days. Number of shares sold short was 5.64 Million shares which calculate 4.59 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $9 to the stock, which implies a rise of 184.81% to its current value. Analysts have been projecting $4 as a low price target for the stock while placing it at a high target of $13. It follows that stock’s current price would jump +311.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of 26.58% for stock’s current value.

Spectrum Pharmaceuticals, Inc. (SPPI) estimates and forecasts

4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $70Million for the same. And 4 analysts are in estimates of company making revenue of $70Million in the next quarter that will end in September 01, 2020. Company posted $1.25 Million of sales in current quarter a year earlier. Analysts are expecting this quarter sales to drop by -94.4%.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.6% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 0.2% while estimates for its earnings growth in next 5 years are of 0%